○Takami Nakao1, Tomoaki Sakamoto2, Takuji Shoda3, Keijiro Suzuki1, Eisaku Terashita1, Masahiro Ota1 (1. X-ray/Suface Business Unit, Analytical & Measuring Instruments Division, Shimadzu Corporation, 2. Division of Drugs, National Insuitute of Health Sciences, 3. Division of Organic Chemistry, National Insuitute of Health Sciences)
Session information
Poster Presentation
(B) Pharmaceutical Physics
[29P-am] Spectroscopic analysis 1/HPLC 1/LC-MS 1/Biological analysis
Fri. Mar 29, 2024 8:30 AM - 12:00 PM [Poster] Exhibition Hall AB (1F)
○Yasunori Hamazaki1,2, Satoko Shimbara-Matsubayashi1, Yuki Odanaka1, Nanami Fukui2, Takashi Yamazaki2, Masaru Kato1 (1. Grad. Sch. Pharm. Sci., Showa Univ., 2. OHTA'S ISAN Co., Ltd.)
○Shinya Takada, Fumiko Hara1, Shizuyo Horiyama1, Masayori Hagimori1 (1. Sch. Pharm., Mukogawa Women's Univ.)
○Naoki Baden1, Norio Urayama1 (1. Nihon Thermal Consulting)
○Takuji Shoda1, Noriaki Fukamachi2, Yosuke Demizu1, Tomoaki Sakamoto1 (1. Natl. Inst. Health Sci., 2. KLV)
○Sae Ueda1, Ryuichiro Suzuki1, Hiroaki Todo1, Yuji Higuchi2, Kenichi Akao2, Takashi Tanikawa1, Yutaka Inoue1 (1. Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 2. JASCO Corporation)
○Koichiro Akiyama1, Kazuki Horita1, Kazuhiro Takahashi1, Hiroshi Satozono1, Tomoaki Sakamoto2 (1. Hamamatsu Photonics K.K., 2. National Institute of Health Sciences)
○Koji Nakayama1, Aya Ikarashi2, Takuma Yokoyama2, Tomoaki Sakamoto3 (1. TOWA PHARMACEUTICAL CO.,LTD., 2. USHIO INC., 3. National Institute of Health Science, MHLW)
○Akane Yokomizo1, Shota Matsumoto1, Kazuteru Usui1, Ken-ichi Yamada2, Satoru Karasawa1 (1. Showa Pharmaceutical Univ., 2. Grad. Sch. Pharm. Sci., Kyushu Univ.)
[29P-am131S] Emission Properties and Organelle-imaging of Push-pull Type Bicyclic Fluorescent Probes
○Ryoma Kato1, Shota Matsumoto1, Tomohiro Umeno1, Kazuteru Usui1, Satoru Karasawa1 (1. Showa Pharmaceutical Univ.)
○Chie Honda1, Kanae Nishimura2, Noboru Hayama3, Jun Haginaka1 (1. Inst. Biosci., Mukogawa Women's Univ., 2. Sch. Pharm. Pharmaceut. Sci., Mukogawa Women's Univ., 3. Fac. Pharm., Osaka Med. Pharm. Univ.)
○Yuki Nakatani1, Daisuke Funatsu1, Tomoka Morita1, Eiichi Yamamoto2, Nozomi Murayama3, Shota Miyazaki3, Masaru Kato4 (1. Sch. Pharm., Showa Univ., 2. National Institute of Health Sciences, 3. GL Sciences Inc., 4. Grad. Sch. Pharm. Sci., Showa Univ.)
○Norihito Maru1, Hiroki Imamura1, Shohei Kosaka1, Makoto Kawai1, Takahiro Miyauchi2 (1. Fuji Silysia Chemical, 2. Daiichi Sankyo RD Novare)
○Tomoyasu Tsukamoto1, Ryuji Koyama1, Norikazu Nagae1 (1. Chromanik Technologies Inc.)
○Itsumi Konno1, Ryota Kujirai2, Mizuki Abe1, Yotaro Matsumoto2, Takaaki Abe3,4, Yoshihisa Tomioka2 (1. Facu. Pharm. Sci., Tohoku Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ., 3. Nephrology and Hypertension, Tohoku Univ. Hosp., 4. Grad. Sch. Biomed. Engin., Tohoku Univ.)
○Tomotaka Mizuguchi1, Kengo Murata1, Hideki Motoda1, Kanji Nagai1, Takafumi Onishi1, Atsushi Ohnishi1 (1. DAICEL CORPORATION)
○Ryu Mochizuki1, Yasumitsu Ogra1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
○Yi-Wen Huang1, Chia-Hsien Feng*2 (1. Master Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Taiwan, 2. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Taiwan)
○Yi-Rou Wang1, Chia-Hsien Feng*1 (1. Department of Fragrance and Cosmetic Science, Collage of Pharmacy, Kaohsiung Medical University, Taiwan)
○Aoi Ichikawa1, Takahiro Takayama1, Shumpei Fujie2, Motoyuki Iemitsu2, Koichi Inoue1 (1. Pharm. Sci., Ritsumeikan Univ., 2. Sport and Health Sci., Ritsumeikan Univ.)
○Tomoya Ohmura1, Shinya Ogata1, Hiroshi Sakamaki1 (1. Chemicals Evaluation and Research Institute, Japan)
[29P-am143] Repeatability assessment of an HPLC method for soft capsules analysis by the FUMI theory
○Ai Sano1, Masato Takahashi1, Akira Kotani2, Hideki Hakamata2 (1. TOYO CAPSULE, 2. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)
○Hirotaka Nishimura1, Noritaka Hashii1, Tomofumi Yamamoto1, Akiko Ishii-Watabe1 (1. National Institute of Health Sciences)
○Akira Harazono1, Hiroko Shibata1, Akiko Watabe Ishii1 (1. National Institute of Health Sciences)
○Masato Shimoi1, Maiko Inoue1, Hajime Mizuno1, Susumu Y. Imanishi1 (1. Fac. Pharm., Meijo Univ.)
○Waka Saito1, Reika Ozeki1, Toru Hasegawa1, Hajime Mizuno1, Susumu Y. Imanishi1 (1. Fac.Pharm.,Meijo Univ.)
○Rira Sato1, Kana Watanabe1, Moeka Kondo1, Akira Yoshimi1,2, Kiyoshi Fujita3, Norio Ozaki2, Yukihiro Noda1,2, Hajime Mizuno1, Susumu Y Imanishi1 (1. Fac. Pharm., Meijo Univ., 2. Grad. Sch. Med., Nagoya Univ., 3. Okehazama Hosp.)
○Hiroki Matsuoka1, Honoka Kaneko2, Hironori Kobayashi3, Takayuki Ishige4, Tatsuya Higashi1 (1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2. Graduate School of Pharmaceutical Sciences, Tokyo University of Science, 3. Clinical Laboratory Division, Shimane University Hospital, 4. Division of Laboratory Medicine, Chiba University Hospital)
○Natsuki Yoshida1, Kazunari Takada2, Ogawa Shoujiro3, Higashi Tatsuya1 (1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2. Graduate School of Pharmaceutical Sciences, Tokyo University of Science, 3. Faculty of Pharmaceutical Sciences, Fukuyama University)
○Rei Hamamoto1, Soo Takasu1, Yukihiro Esaka1,2 (1. Gifu Pharm. Univ., 2. United Grad. Sch. of Drug Discovery and Medical Information Sci. , Gifu Univ. )
○Mami Akao1, Chisato Takahashi1, Muneshige Tokugawa1, Masaki Ri2, Shinsuke Iida2, Keiko Maekawa1 (1. Doshisha Women's College of Liberal Arts, 2. Grad. Sch. Medical Sci., NAGOYA CITY Univ.)
○Mana Nakazawa1, Muneshige Tokugawa1, Chisato Takahashi1, Keiko Maekawa1 (1. Doshisha Women's College of Liberal Arts)
○Tsuyoshi Murai1, Sato Kousuke1, Takahiro Sasaki1 (1. Sch. Pharm. Sci., Health Sci. Univ. Hokkaido)
Chika Kanno1, ○Natsuki Sano1, Masamitsu Maekawa1,2,3, Izumi Sakamoto3, Yosihide Kawasaki3, Akihiro Ito3, Nariyasu Mano1,2,3 (1. Fac. of Pharm. Sci., Tohoku Univ., 2. Dept. Pharm. Sci., Tohoku Univ. Hosp., 3. Grad. Sch. Med., Tohoku Univ.)
○Atsushi Ishizaki1, Yurika Hara1, Hiroyuki Kataoka1 (1. School of Pharmacy, Shujitsu University)
○Yutaka SADAKANE1, Akari Tsubokura1, Mitsuki Kasai1, Yuka Ito1, Chihiro Ito1, Shota Morimoto1 (1. Suzuka Univ. Med. Sci.)
○Yoshinori Kato1,2, Yuni Ichikawa1, Yui Kataoka1, Takuya Hirao1, Takeshi Ito1, Chihiro Tetsuka1, Harumi Yamada1,2 (1. Sch. Pharm., IUHW, 2. Grad. Sch. Pharm. Sci., IUHW)
○Tatsuya Sakamoto1, Hiroshi Sugasawa1, Mayu Onozato1, Takeshi Fukushima1 (1. Pharm. Sci., Toho Univ.)
○Ryo Fukushima1, Ibuki Nakano1, Yuina Ogura1, Katou Masaru2 (1. Sch. Pharm., Showa Univ., 2. Grad. Sch. Pharm. Sci., Showa Univ.)
○Hsi-Chih Huang1, Pei-Yun Tsai1, Yu-Ning Chang1, Jen-Ai Lee*1 (1. Pharm. Taipei Medical Univ.)
○Yu-Ning Chang1, Pei-Yun Tsai1, Hsi-Chih Huang1, Shwu-Huey Wang2, Jen-Ai Lee*1 (1. Pharm. Taipei Medical Univ. , 2. The Core Facility Center. Taipei Medical Univ.)